2008
DOI: 10.1086/592255
|View full text |Cite
|
Sign up to set email alerts
|

Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis

Abstract: Identification of predictors of death helps in the identification of patients who could benefit from more-aggressive therapeutic strategies. Initiation of therapy at the stage of possible infection improves outcome, and this finding calls for the development of efficient preemptive strategies to fill the gap between empirical and directed therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
264
4
8

Year Published

2009
2009
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 316 publications
(295 citation statements)
references
References 28 publications
15
264
4
8
Order By: Relevance
“…2,3 Since past studies frequently focused on groups of patients with marked diversity in risk, disease, disease stage, and type of transplant they were unable to provide clear conclusions about the impact of individual risk factors on outcome. [12][13] To avoid such confounding factors, the present analysis focused only on patients with AML who received standard chemotherapy and who had proven/probable invasive aspergillosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2,3 Since past studies frequently focused on groups of patients with marked diversity in risk, disease, disease stage, and type of transplant they were unable to provide clear conclusions about the impact of individual risk factors on outcome. [12][13] To avoid such confounding factors, the present analysis focused only on patients with AML who received standard chemotherapy and who had proven/probable invasive aspergillosis.…”
Section: Discussionmentioning
confidence: 99%
“…The remaining 12 patients received only targeted therapy (9%). The mean period between symptom onset and the start of empirical/preemptive treatment was 6 days (range, [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. The difference between times to treatment was not significant (symptoms to empirical therapy, 1-18 days, mean 5 days; symptoms to pre-emptive therapy 1-19 days, mean 6 days).…”
Section: Treatmentmentioning
confidence: 99%
“…In high risk neutropenic patients, the mortality rate related with systemic candidiasis has been reported to be 50% and to invasive aspergillosis as high as 80-100% (20). The most important factor which has been shown to affect survival is neutropenia in invasive fungal infections (21,22). The most important reason for lack of improvement of neutropenia is absence of response of accompanying malignancy to treatment.…”
Section: Candida Albicansmentioning
confidence: 99%
“…The more serious form of the disease is invasive pulmonary aspergillosis, which is most common in individuals with defective immune systems; users of immunosuppressive therapies, such as those used to prevent rejection following organ transplantation; and individuals at latestage human immunodeficiency virus infection. Survival rates in humans are ;50% (Nivoix et al 2008).…”
Section: [Supplemental Materials Is Available For This Article]mentioning
confidence: 99%